RS Research Funding: How Much Did They Raise & Key Investors

How Much Did RS Research Raise?
Funding & Key Investors

RS Research, a clinical-stage biotechnology firm, has successfully secured significant capital to advance its proprietary nanomedicine pipeline. The company has reached a cumulative milestone of $13.2M in total financing, bolstered by a recent strategic investment of $12M. This influx of capital underscores investor confidence in the firm's innovative drug delivery platforms, which are specifically engineered to address complex oncology challenges. By leveraging these resources, RS Research is well-positioned to accelerate its clinical development trajectory and expand its footprint in the global therapeutic landscape.

The company's growth trajectory, marked by a transition from early-stage private equity to more substantial enterprise-level backing, reflects a maturing business model. As the firm moves deeper into clinical trials, this latest round of financing provides the necessary runway to validate its nanomedicine technology against established standards of care in cancer treatment.

What is RS Research?

RS Research

Manufacturing

Pharmaceuticals

Business Services

Founded in 2015 and headquartered in Turkey, RS Research operates at the intersection of nanotechnology and oncology. The company specializes in the development of novel nanomedicines designed to enhance the efficacy and safety profiles of cancer therapies. By focusing on innovative drug delivery systems, RS Research aims to overcome the limitations of conventional chemotherapy, offering more targeted and potent treatment options for patients. The firm's market position is defined by its commitment to deep-tech research and its ability to translate complex scientific concepts into viable clinical assets, making it a notable player in the burgeoning biotech sector.

How much funding has RS Research raised?

RS Research has raised a total of $13.2M across 2 funding rounds:

2017

Private Equity

$1.2M

2021

Series A

$12M

Private Equity (2017): $1.2M with participation from ACT Venture Partners

Series A (2021): $12M led by Eczacıbaşı Momentum, GEN Ilaç, and One life Ventures

Key Investors in RS Research

ACT Venture Partners

ACT Venture Partners is a venture capital firm that invests in early stage deep-tech startups, focusing on sectors such as AI, IoT, and Big Data.

One life Ventures

One life Ventures is a firm operating in the banking and investment sector, providing strategic capital to high-growth enterprises.

Eczacıbaşı Momentum

Eczacıbaşı Momentum is a corporate venture capital arm focused on supporting innovative startups that align with the broader industrial and healthcare goals of the Eczacıbaşı Group.

What's next for RS Research?

With the recent infusion of capital, RS Research is expected to prioritize the advancement of its lead candidates through critical clinical phases. The strategic focus will likely center on scaling manufacturing capabilities and strengthening regulatory submissions to ensure the commercial viability of its nanomedicine platforms. Furthermore, the company is poised to enhance its research and development infrastructure, potentially exploring new therapeutic indications for its delivery technology. As the firm continues to navigate the complexities of the biotech industry, its ability to maintain high-quality clinical data will be paramount in securing future partnerships and long-term market sustainability.

See full RS Research company page

See More Financial Insights

No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Bay Shore Systems

Industrial Machinery & Equipment

Manufacturing

N-Drip

Industrial Machinery & Equipment

Manufacturing

RevAir

Appliances

Manufacturing

Quest & Sons

Manufacturing

Textiles & Apparel

Frequently Asked Questions Regarding RS Research Financial Insights

What are the most recent funding rounds that RS Research has completed, and what were the funding rounds?

RS Research has recently completed 2 funding rounds: Series A on Dec 17, 2021, Private Equity on Apr 21, 2017.

What is the total amount of funding RS Research has raised to date?

RS Research has raised a total of $13.2M in funding to date.

How many funding rounds has RS Research completed?

RS Research has completed 2 funding rounds.

How much funding did RS Research raise in its most recent funding round?

RS Research raised $12M in its most recent funding round.

Who are the lead investors in RS Research's latest funding round?

The lead investor in RS Research's latest funding round was Eczacıbaşı Momentum. To access investor data and explore similar companies, sign up for ZoomInfo.

Which was the largest funding round in RS Research's history?

The largest funding round in RS Research's history was $12M.

See more information about RS Research